Document is current
Any future updates will be listed below
-
Authors
Córdoba-Lanús, E. https://orcid.org/0000-0001-5534-8280
Cazorla-Rivero, S.
García-Bello, M. A.
Mayato, D.
Gonzalvo, F.
Ayra-Plasencia, J.
Celli, B.
Casanova, C.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (12/00355)
Sociedad Española de Neumología y Cirugía Torácica (13/007)
Menarini
- License Information
-
More Information
Article History
Received: 18 November 2020
Accepted: 6 January 2021
First Online: 15 February 2021
Ethics approval and consent to participate
: Written informed consent was obtained from all participants. Ethical approval was obtained from Hospital Universitario La Candelaria, Tenerife, Spain (PI14/12).
: Not applicable.
: Elizabeth Córdoba-Lanús, Sara Cazorla-Rivero, Miguel-Angel García-Bello, Delia Mayato, Francisca Gonzalvo-Hernández and Jessel Ayra-Plasencia declare not to have any financial or personal conflict of interests. Ciro Casanova Macario declares to have received lectures and / or scientific advice from Laboratorios Bial, Boehringer-Ingelheim, Gebropharma, GSK, Esteve, Menarini, Novartis and Rovi in the last 3 years. Bartolomé Celli declares to have received grants from Astra Zeneca; advisory board payments from Glaxo Smith Kline, Boehringer-Ingelheim, Astra Zeneca and Novartis, Pulmonix; and declares not to have shares or interest in any company, neither have received or had any relationship with tobacco money.
